{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T05:22:50Z","timestamp":1788326570824,"version":"build-2803163510"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>The primary treatments for Graves\u2019 disease include antithyroid drugs (ATD), thyroidectomy, and iodine-131 (I-131) therapy. This study aimed to identify factors predicting treatment outcomes and the treatment period required to achieve euthyroidism after I-131 administration.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This study included 109 patients with Graves\u2019 disease who underwent I-131 therapy. Patients achieving euthyroidism or hypothyroidism within 1 year were classified as the success group, whereas those with remaining hyperthyroidism were classified as the failure group. Thyroid volume, computed tomography (CT) values, 24-h radioiodine uptake, effective half-life, the levels of free triiodothyronine, free thyroxine, thyroid-stimulating hormone, and thyrotropin receptor antibody, history of I-131 therapy, history of ATD use, history of potassium iodide use, and thyroid absorbed dose were analysed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Larger thyroid volume [odds ratio = 0.982, 95% confidence interval (CI): 0.967\u20130.998,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u20050.05] was identified as a predictive factor for treatment failure, as determined by multivariable logistic regression. In contrast, a shorter treatment period was associated with lower thyroid volume (hazard ratio\u2005=\u20050.990, 95% CI: 0.982\u20130.999,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u20050.05), higher thyroid absorbed dose (hazard ratio\u2005=\u20051.007, 95% CI: 1.002\u20131.011,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u20050.01), and lower thyroid CT values (hazard ratio\u2005=\u20050.963, 95% CI: 0.939\u20130.987,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u20050.01), as identified by multivariable Cox regression.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Larger thyroid volume was associated with treatment failure. Smaller thyroid volume, higher thyroid absorbed dose, and lower thyroid CT values were significant predictors of the treatment period required to achieve euthyroidism after I-131 administration.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/mnm.0000000000002045","type":"journal-article","created":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T13:00:10Z","timestamp":1756731610000},"page":"1180-1185","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Predictive factors for the efficacy of radioiodine therapy in patients with Graves\u2019 disease"],"prefix":"10.1097","volume":"46","author":[{"given":"Haruna","family":"Iwanaga","sequence":"first","affiliation":[{"name":"Department of Radiological Technology, Nagoya University Hospital"},{"name":"Departments of Radiological and Medical Laboratory Sciences, Integrated Health Science"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naotoshi","family":"Fujita","sequence":"additional","affiliation":[{"name":"Department of Radiological Technology, Nagoya University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Abe","sequence":"additional","affiliation":[{"name":"Department of Radiological Technology, Nagoya University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rintaro","family":"Ito","sequence":"additional","affiliation":[{"name":"Innovative BioMedical Visualization (iBMV)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumi","family":"Abe","sequence":"additional","affiliation":[{"name":"Radiology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryogo","family":"Minamimoto","sequence":"additional","affiliation":[{"name":"Integrated Image Information Analysis, Nagoya University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryuichi","family":"Nishii","sequence":"additional","affiliation":[{"name":"Functional Medical Imaging, Biomedical Imaging Sciences, Division of Advanced, Information Health Sciences, Department of Integrated Health Sciences, Nagoya University Graduate School of Medicine, Nagoya, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Naganawa","sequence":"additional","affiliation":[{"name":"Radiology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuhiko","family":"Kato","sequence":"additional","affiliation":[{"name":"Functional Medical Imaging, Biomedical Imaging Sciences, Division of Advanced, Information Health Sciences, Department of Integrated Health Sciences, Nagoya University Graduate School of Medicine, Nagoya, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,9,1]]},"reference":[{"key":"R1-20251106","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/s41572-020-0184-y","article-title":"Graves\u2019 disease.","volume":"6","author":"Davies","year":"2020","journal-title":"Nat Rev Dis Primers"},{"key":"R2-20251106","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1159\/000490384","article-title":"2018 European Thyroid Association guideline for the management of Graves\u2019 hyperthyroidism.","volume":"7","author":"Kahaly","year":"2018","journal-title":"Eur Thyroid J"},{"key":"R3-20251106","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1089\/thy.2016.0229","article-title":"2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis.","volume":"26","author":"Ross","year":"2016","journal-title":"Thyroid"},{"key":"R4-20251106","doi-asserted-by":"crossref","first-page":"3324","DOI":"10.1007\/s00259-023-06274-5","article-title":"The EANM guideline on radioiodine therapy of benign thyroid disease.","volume":"50","author":"Campenn\u00ec","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R5-20251106","doi-asserted-by":"crossref","first-page":"4549","DOI":"10.1210\/jc.2012-2802","article-title":"A 2011 survey of clinical practice patterns in the management of Graves\u2019 disease.","volume":"97","author":"Burch","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"R6-20251106","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.2967\/jnumed.112.105148","article-title":"The SNMMI practice guideline for therapy of thyroid disease with 131I 3.0.","volume":"53","author":"Silberstein","year":"2012","journal-title":"J Nucl Med"},{"key":"R7-20251106","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1001\/jama.1983.03340150084036","article-title":"History of the discovery and early use of radioactive iodine.","volume":"250","author":"Chapman","year":"1983","journal-title":"JAMA"},{"key":"R8-20251106","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1172\/JCI101275","article-title":"Radioactive iodine as an indicator in thyroid physiology. IV. The metabolism of iodine in Graves\u2019 disease.","volume":"21","author":"Hertz","year":"1942","journal-title":"J Clin Invest"},{"key":"R9-20251106","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1089\/thy.2021.0302","article-title":"A systematic review and meta-analysis of the relationship between the radiation absorbed dose to the thyroid and response in patients treated with radioiodine for Graves\u2019 disease.","volume":"31","author":"Taprogge","year":"2021","journal-title":"Thyroid"},{"key":"R10-20251106","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1210\/er.2012-1030","article-title":"Radioiodine therapy in benign thyroid diseases: effects, side effects, and factors affecting therapeutic outcome.","volume":"33","author":"Bonnema","year":"2012","journal-title":"Endocr Rev"},{"key":"R11-20251106","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1148\/radiology.147.3.6844615","article-title":"Thyroid CT number and its relationship to iodine concentration.","volume":"147","author":"Iida","year":"1983","journal-title":"Radiology"},{"key":"R12-20251106","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2214\/AJR.09.3319","article-title":"Diagnostic value of CT density in patients with diffusely increased FDG uptake in the thyroid gland on PET\/CT images.","volume":"195","author":"Han","year":"2010","journal-title":"AJR Am J Roentgenol"},{"key":"R13-20251106","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/RCT.0000000000000360","article-title":"Correlation between computed tomography density and functional status of the thyroid gland.","volume":"40","author":"Pandey","year":"2016","journal-title":"J Comput Assist Tomogr"},{"key":"R14-20251106","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s12149-024-01938-0","article-title":"Correlation between the thyroid computed tomography value and thyroid function in hyperthyroidism: a retrospective study.","volume":"38","author":"Iwanaga","year":"2024","journal-title":"Ann Nucl Med"},{"key":"R15-20251106","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/00004728-199103000-00019","article-title":"Measurement of thyroid iodine by CT.","volume":"15","author":"Imanishi","year":"1991","journal-title":"J Comput Assist Tomogr"},{"key":"R16-20251106","first-page":"260","article-title":"Dosage determination with radioactive isotopes; practical considerations in therapy and protection.","volume":"59","author":"Marinelli","year":"1948","journal-title":"Am J Roentgenol Radium Ther"},{"key":"R17-20251106","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/MNM.0b013e328333d303","article-title":"Radioiodine therapy of benign thyroid disorders: what are the effective thyroidal half-life and uptake of 131I?","volume":"31","author":"Kobe","year":"2010","journal-title":"Nucl Med Commun"},{"key":"R18-20251106","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1097\/MNM.0000000000000285","article-title":"Factors influencing the success of radioiodine therapy in patients with Graves\u2019 disease.","volume":"36","author":"\u0160filigoj","year":"2015","journal-title":"Nucl Med Commun"},{"key":"R19-20251106","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1365-2265.2008.03291.x","article-title":"Prediction of cure and risk of hypothyroidism in patients receiving 131I for hyperthyroidism.","volume":"70","author":"Boelaert","year":"2009","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R20-20251106","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/MNM.0000000000000770","article-title":"Prognostic factor analysis in 325 patients with Graves\u2019 disease treated with radioiodine therapy.","volume":"39","author":"Yang","year":"2018","journal-title":"Nucl Med Commun"},{"key":"R21-20251106","doi-asserted-by":"crossref","first-page":"BSR20191609","DOI":"10.1042\/BSR20191609","article-title":"Predictive factors for the outcomes of Graves\u2019 disease patients with radioactive iodine (131I) treatment.","volume":"40","author":"Xing","year":"2020","journal-title":"Biosci Rep"},{"key":"R22-20251106","doi-asserted-by":"crossref","first-page":"7535093","DOI":"10.1155\/2024\/7535093","article-title":"Predictive factors for the efficacy of radioactive iodine treatment of Graves\u2019 disease: an experience from 613 Chinese patients.","volume":"2024","author":"Feng","year":"2024","journal-title":"Int J Endocrinol"},{"key":"R23-20251106","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/RLU.0b013e3182817c78","article-title":"High failure rates after 131I therapy in Graves\u2019 hyperthyroidism patients with large thyroid volumes, high iodine uptake, and high iodine turnover.","volume":"38","author":"de Jong","year":"2013","journal-title":"Clin Nucl Med"},{"key":"R24-20251106","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1097\/MNM.0b013e3283559ba1","article-title":"Radioiodine therapy in Graves\u2019 disease: is it possible to predict outcome before therapy?","volume":"33","author":"Isgoren","year":"2012","journal-title":"Nucl Med Commun"},{"key":"R25-20251106","first-page":"1073","article-title":"High dose (131)I therapy for the treatment of hyperthyroidism caused by Graves\u2019 disease.","volume":"87","author":"Alexander","year":"2002","journal-title":"J Clin Endocrinol Metabol"},{"key":"R26-20251106","first-page":"3611","article-title":"Radioiodine treatment of hyperthyroidism prognostic factors for outcome.","volume":"86","author":"Allahabadia","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"R27-20251106","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/cen.13873","article-title":"Predicting outcomes and complications following radioiodine therapy in Graves\u2019 thyrotoxicosis.","volume":"90","author":"Aung","year":"2019","journal-title":"Clin Endocrinol (Oxf)"}],"container-title":["Nuclear Medicine Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MNM.0000000000002045","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T14:00:57Z","timestamp":1762437657000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MNM.0000000000002045"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,1]]},"references-count":27,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/mnm.0000000000002045","relation":{},"ISSN":["0143-3636","1473-5628"],"issn-type":[{"value":"0143-3636","type":"print"},{"value":"1473-5628","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,1]]},"assertion":[{"value":"2025-05-21","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-18","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}